Abstract: Methods and vaccines for the production of antibodies to infectious organisms are described. Live recombinant adenovirus containing a foreign gene coding for an antigen produced by another infectious organism is delivered to the intestine of a warm-blooded animal in an enteric-coated dosage form, whereupon the virus infects the gut wall and induces the production of antibodies or cell mediated immunity to both adenovirus and the other infectious organism.
Abstract: Pentapeptides of the formula: ##STR1## wherein R.sup.1 is hydrogen, methyl, ethyl, propyl, 2-methyl-2-pentenyl, 2-methyl-1-pentenyl, cyclopropylmethyl, or cyclobutylmethyl; R.sup.2, R.sup.3, and R.sup.4 are, independently, hydrogen or methyl; and X is --OH, --NH.sub.2, --NHC.sub.n H.sub.2n+1 where n is 1, 2, 3, or 4, --OR.sup.3, or CH.sub.2 OR.sup.3, where R.sup.3 is hydrogen or lower alkyl of from 1 to 4 carbon atoms; or a pharmaceutically acceptable salt thereof; have analgesic activity upon administration to warm-blooded animals.
Abstract: The use of 3-aryl-thiazolo[3,2-a]benzimidazoles, 3-aryl-imidazo[2,1-b]thiazoles, and related compounds as antineoplastic agents, and/or as enhancers of the immune response is disclosed.
Type:
Grant
Filed:
July 18, 1978
Date of Patent:
July 22, 1980
Assignee:
American Home Products Corporation
Inventors:
Richard L. Fenichel, Peter H. L. Wei, Francis J. Gregory, Harvey E. Alburn
Abstract: Novel dipeptides of the formula: A--X--Y--B wherein X is D-Tyr or L-Tyr; Y is D-Ala, L-Ala, D-Ser, L-Ser, or Gly; with the proviso that at least one of X and Y is of the D- configuration; A is hydrogen, allyl, or lower alkyl of 1 to 3 carbon atoms; B is --NH.sub.2, --OMe, or --NHNH.sub.2 ; and the pharmacologically acceptable salts thereof, as well as pharmaceutical compositions containing them, and a process for antagonizing the effects of a narcotic analgesic agent in warm blooded animals are disclosed.
Type:
Grant
Filed:
September 29, 1978
Date of Patent:
May 27, 1980
Assignee:
American Home Products Corporation
Inventors:
James D. Beluzzi, William H. McGregor, Larry Stein
Abstract: Reaction of benzalcyclanones with secondary amines affords aminobenzylcyclohexanones, which, upon reduction, yield aminobenzylcyclohexanols having potent analgesic activity. Epimeric aminobenzylcycloalkanols having analgesic activity are prepared by the reaction of C-phenyl nitrones with cycloalkenes to form benzisoxazoles, treatment with alkyl halide to form the corresponding benzisoxazolium halides, followed by hydrogenolysis.
Abstract: Derivatives of 13,14-dihydro-PGE.sub.2 and 5,6; 13,14-tetrahydro-PGE.sub.2 are prepared. These new compounds not heretofore found in nature display activity as bronchodilator agents.
Abstract: Derivatives of PGD.sub.2 are prepared. These new compounds not heretofore found in nature display pharmacological activity, for example, inhibition of blood platelet aggregation.
Abstract: Cyclic undecapeptides of the general formula ##STR1## WHEREIN N IS AN INTEGER OF FROM 3 TO 8 AND T may be either L-Trp or D-Trp are disclosed. These compounds inhibit the release of pituitary growth hormome, glucagon, and insulin.
Abstract: Somatostatin analogs which contain certain D-amino acid residues are disclosed. These analogs contain, in addition to a D-Trp.sup.8 residue, glycyl or D-amino acid residues in positions 4 and 5.These compounds inhibit the release of pituitary growth hormone, glucagon, and insulin.
Abstract: The use of quaternary salts of promethazine by the inhalation route is described. The thus administered compositions provide new, non-toxic, potent means for relieving bronchial spasm and bronchoconstriction in warm-blooded animals.
Type:
Grant
Filed:
November 2, 1976
Date of Patent:
June 27, 1978
Assignee:
American Home Products Corporation
Inventors:
Albert J. Begany, Marvin E. Rosenthale, Alphonse Dervinis
Abstract: 9-Oxo-15-Substituted prostanoic acids, and intermediates for their preparation are disclosed. The final products have bronchodilatory activity.
Abstract: Derivatives of 13,14-dihydro-PGE.sub.2 and 5,6; 13,14-tetrahydro-PGE.sub.2 are prepared. These new compounds not heretofore found in nature display activity as bronchodilator agents.
Abstract: Processes for the total synthesis of dl-11-deoxy-15-substituted prostaglandins, novel intermediates therefore, certain novel final products, as well as optical resolutions of the final products are disclosed.The final products are bronchodilators.
Abstract: Somatostatin analogs which contain L-Arg.sup.4 -L-His.sup.5 amino acids residues in place of the normally present L-Lys.sup.4 -L-Asn.sup.5 residues are disclosed. Other modifications of somatostatin are also disclosed.These compounds inhibit the release of pituitary growth hormone, glucagon, and insulin.
Abstract: A process for increasing the production of enterotoxin by Vibrio cholerae, and enterotoxigenic strains of Escherichia coli, is disclosed. This process produces enhanced amounts of enterotoxin activity compared to amounts obtainable by practice of standard procedures.
Abstract: 1,3-Bridged-2-amino tetralins, having spiro substitution or the bridge, and intermediates thereto. The final products have analgesic activity.
Abstract: 7-(2.beta.-[(3S)-3-Ethynyl-3-hydroxy-trans-1-octenyl]-3.alpha.-hydroxy-5-ox o-1.alpha.-cyclopentyl)-cis-5-heptenoic acid, 2.beta.-[(3S)-3-ethynyl-3-hydroxy-trans-1-octenyl]-3.alpha.-hydroxy-5-oxo- 1.alpha.-cyclopentane heptanoic acid, related compounds, and intermediates thereto are disclosed. The final products have activity as bronchodilators and in reducing gastric secretion.
Abstract: 9-Oxo-15-substituted prostanoic acids, and intermediates for their preparation and for the preparation of other known prostaglandins are disclosed. The final products have bronchodilatory activity.
Abstract: Prostaglandin compounds substituted at the 11-position with a methyl group are prepared from PGA.sub.2, its 15-epimer, and their esters. These compounds, not heretofore found in nature, possess a variety of pharmacological activities one of which is bronchodilation.